Observational study finds adults taking 5,000 IU vitamin D scored 13% higher — Evidence Review

Adults with mild cognitive impairment (MCI) and sleep disturbances who took at least 5,000 IU of vitamin D daily scored over 13% higher on a cognitive test compared to those not supplementing, according to a new study from Emory University. However, evidence from previous research on vitamin D supplementation and cognitive function has been mixed.

• While several randomized controlled trials (RCTs) and meta-analyses have found limited or no significant cognitive benefits from vitamin D supplementation in older adults or those with MCI, some studies suggest possible improvements in specific cognitive domains or in certain high-risk populations 2 4 5 6 7.
• Observational studies consistently report associations between low vitamin D levels and poorer cognitive performance, but intervention studies often fail to show clear benefits, indicating that timing, dosage, or population characteristics may influence outcomes 1 2 6.
• The new study’s focus on individuals with both sleep disturbances and MCI—a group at high risk for dementia—distinguishes it from prior work, which often studied broader or healthier populations and used lower vitamin D doses 5 7.

Study Overview and Key Findings

Alzheimer’s disease and related dementias are major and growing public health concerns, with millions at risk and few effective early interventions. This study is notable for targeting adults with both MCI and sleep disturbances, two factors linked to elevated dementia risk and potentially modifiable through lifestyle or nutritional interventions. By examining vitamin D supplementation in this specific high-risk group, the researchers aimed to identify accessible strategies to support brain health during early cognitive decline.

Property	Value
Study Year	2026
Organization	Emory University
Journal Name	Sleep Medicine
Authors	Sirui Zhou, Paul Sudeshna, Lynn Marie Trotti, Donald Bliwise, Victoria Pak
Population	Adults with mild cognitive impairment and sleep disturbances
Sample Size	54 adults
Methods	Observational Study
Outcome	Cognitive function scores
Results	Participants taking 5,000 IU of vitamin D scored 13% higher.

Literature Review: Related Studies

To place these findings in context, we searched the Consensus research database, which contains over 200 million papers. The following search queries were used to identify relevant literature:

1. vitamin D cognitive performance adults
2. high dose vitamin D cognitive outcomes
3. vitamin D supplementation cognitive test results

Topic	Key Findings
Do low vitamin D levels increase risk for cognitive decline or impairment?	- Low vitamin D status is associated with poorer cognitive performance and increased risk of cognitive decline in observational studies 1 2 6. - Evidence for a clear causal role remains inconclusive, with some studies finding no association for specific cognitive domains or after adjusting for confounders 1.
Does vitamin D supplementation improve cognition in adults with or without impairment?	- Most RCTs and meta-analyses show no significant cognitive benefit from vitamin D supplementation in non-demented older adults or those with MCI, though some improvements are seen in certain cognitive domains or subgroups 2 4 5 6 7. - Some studies report small improvements in nonverbal (visual) memory or in participants with low baseline vitamin D 4 5.
What is the effect of high-dose vitamin D supplementation on cognition?	- High-dose vitamin D supplementation (e.g., 4,000–5,000 IU/day) is rarely studied but may improve select cognitive domains, such as nonverbal memory, particularly in those with low baseline vitamin D status 4. - Most intervention studies use lower doses (800–2,000 IU/day) and typically find little or no overall cognitive benefit 3 5 6 7.
Are there specific populations more likely to benefit from vitamin D supplementation?	- Individuals with MCI, sleep disturbances, or low baseline vitamin D may be more likely to benefit from supplementation 5 6. - Some evidence suggests modest cognitive benefits in older Black adults, and in those with Alzheimer’s disease, but results are inconsistent and require further confirmation 3 5 6.

Do low vitamin D levels increase risk for cognitive decline or impairment?

Observational studies consistently associate low vitamin D status with an increased risk of poorer cognitive performance and cognitive decline in midlife and older adults. However, the causality of this relationship remains uncertain, and prospective or interventional evidence is mixed, with some studies finding no significant association for certain cognitive domains or after adjustment for confounding variables 1 2 6. The new Emory study supports the idea of a link between vitamin D and cognitive performance, but its observational design limits conclusions about causality.

• Several large observational studies found that low serum 25-hydroxyvitamin D levels are associated with poorer global cognitive function and increased risk of cognitive decline 1 2 6.
• The magnitude of association varies, and some studies do not find significant relationships for specific cognitive tasks or after controlling for confounders 1.
• The new study aligns with this observational evidence, but like previous work, it cannot confirm a direct causal effect.
• Understanding whether low vitamin D is a marker or a cause of cognitive decline remains a major research question 1 2.

Does vitamin D supplementation improve cognition in adults with or without impairment?

The majority of randomized controlled trials and meta-analyses have not found significant cognitive benefits of vitamin D supplementation, especially in community-dwelling older adults without dementia or in those with MCI. Some studies, however, suggest domain-specific or subgroup effects, and a few RCTs in individuals with Alzheimer’s disease or MCI report improvements in certain cognitive tests after vitamin D supplementation 2 3 4 5 6 7. The Emory study’s finding of cognitive benefit at high doses in a high-risk group is notable, though it contrasts with much of the broader literature.

• Systematic reviews and meta-analyses generally report no significant effect of vitamin D supplementation on global cognition in adults without dementia 2 6 7.
• Some RCTs have observed small improvements in specific domains such as nonverbal memory or IQ, especially in participants with low baseline vitamin D or specific forms of cognitive impairment 4 5.
• The new study’s focus on MCI and sleep disturbance may explain why it found a positive effect, as these subgroups could be more responsive 5.
• The possibility of a therapeutic window—where intervention is most effective early in cognitive decline—remains an open question 2.

What is the effect of high-dose vitamin D supplementation on cognition?

There is limited research on high-dose vitamin D supplementation (above 2,000 IU/day) and cognitive outcomes. One RCT using 4,000 IU/day found improvements in nonverbal memory for healthy adults with low baseline vitamin D, but most intervention studies use lower doses and observe limited or no cognitive benefit 4. The Emory study, which used 5,000 IU/day, adds to this small body of evidence suggesting that higher doses may have a greater impact, at least in high-risk groups, but further research is needed to confirm safety and efficacy.

• Most RCTs use 800–2,000 IU/day, finding little or no effect on overall cognition 3 5 6 7.
• High-dose supplementation (4,000 IU/day) improved nonverbal memory but not other cognitive domains in healthy adults 4.
• The new study’s use of 5,000 IU/day in people with MCI and sleep disturbances is unique and suggests possible dose-dependent effects.
• There is a need for more studies to determine the optimal dosing strategy for cognitive outcomes 4.

Are there specific populations more likely to benefit from vitamin D supplementation?

Some evidence suggests that certain groups—such as those with MCI, sleep disturbances, low vitamin D status, or specific ethnic backgrounds—may derive greater cognitive benefits from vitamin D supplementation 5 6. For example, one large trial found modest benefits for older Black adults, while others found improvements in MCI or Alzheimer’s disease populations 3 5 6. The Emory study’s focus on a high-risk group (MCI plus sleep disturbance) is aligned with this targeted approach.

• RCTs in participants with MCI or Alzheimer’s disease show some cognitive improvements with supplementation, especially in mechanistic or biomarker outcomes 3 5.
• Older Black adults may experience modest cognitive benefits from vitamin D supplementation, though results require confirmation 6.
• Individuals with low baseline vitamin D appear more likely to benefit from higher doses 4.
• The new study contributes by identifying MCI plus sleep disturbance as a subgroup that may be particularly responsive to high-dose supplementation.

Future Research Questions

Given the mixed results in the literature and the limitations of current studies, further research is needed to clarify the role of vitamin D supplementation in cognitive health. Key areas for investigation include optimal dosing, timing, and identification of populations most likely to benefit.

Research Question	Relevance
Does high-dose vitamin D supplementation improve cognition in adults with mild cognitive impairment?	High-dose supplementation has shown promise in select studies, but evidence is limited and inconsistent. Controlled trials are needed to verify efficacy and safety in the MCI population 4 5.
What is the optimal dose and duration of vitamin D supplementation for cognitive benefits?	Existing studies use a wide range of doses and durations, with mixed results. Determining the most effective and safe regimen is critical for clinical recommendations 4 5 6.
Are there specific subgroups of older adults who benefit most from vitamin D supplementation for cognition?	Evidence suggests that individuals with MCI, sleep disturbances, low vitamin D, or certain ethnic backgrounds may respond differently to supplementation. Identifying these groups could lead to more targeted interventions 5 6.
How does vitamin D supplementation interact with other lifestyle factors (e.g. exercise, sleep) to influence cognitive outcomes?	Multidomain interventions (exercise, cognitive training, vitamin D) may have additive or synergistic effects. Clarifying these interactions may improve dementia prevention strategies 7.
What are the long-term effects and safety of high-dose vitamin D supplementation in older adults?	Few studies have examined the long-term impact and safety profile of high-dose vitamin D, which is especially important given concerns about toxicity and the aging population's vulnerability 4 6.